Stocks Health care CRIS
NASDAQ · Health careCuris Inc (CRIS)
Curis Inc brought in $4.3M of revenue over the twelve months to June 30, 2026, down 62.2% from a year earlier. It posted a net loss of $21.2M. At June 30, 2026 it held $5.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about Curis Inc
- Net worth
- Curis Inc has a market value (market cap) of $1.4M at the latest share price, and shareholders' equity of $4.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $9.4M (-13.4% year on year), with a net loss of $7.6M. Over the 12 months to June 30, 2026: revenue $4.3M, net loss $21.2M.
- Cash flow
- In fiscal 2025 operations used $27.2M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What Curis Inc does
Curis Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CRIS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $9.4M | -$7.6M | -$0.58 | n/a |
| 2024 | $10.9M | -$43.4M | -$6.88 | n/a |
| 2023 | $10M | -$47.4M | -$8.96 | -$38.4M |
| 2022 | $10.2M | -$56.7M | -$12.14 | -$54.8M |
| 2021 | $10.6M | -$45.4M | $0.50 | -$37.6M |
| 2020 | $10.8M | -$29.9M | -$0.61 | -$26.4M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CRIS ranks in Health care
Latest SEC filings
What Curis Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026
- August 10, 2026IPO registration S-1
- July 30, 2026
- July 2, 2026
- July 1, 2026
- July 1, 2026
- June 25, 2026
- June 5, 2026Proxy statement DEF 14A
- May 22, 2026Preliminary proxy statement PRE 14A
- May 22, 2026
Insider trades
What the people running Curis Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| March 31, 2026 | Kaitin Kenneth IDirector | Bought | 10,000 | $5.5K |
| March 20, 2026 | Rubin MarcDirector | Exercised options | 26,667 | - |
| March 20, 2026 | Dentzer James EPresident & CEO, Director | Exercised options | 133,333 | - |
| March 20, 2026 | Duvall DianthaCFO | Exercised options | 66,666 | - |
| March 20, 2026 | Hamdy Ahmed MDCMO | Exercised options | 66,667 | - |
| March 20, 2026 | Zung Jonathan B.CDO | Exercised options | 66,667 | - |
Who owns CRIS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Nantahala Capital Management, LLC13G, passive with 2 related filers | 9.99% | April 24, 2026 |
| Bleichroeder LP13G, passive with 2 related filers | 9.9% | March 31, 2025 |
| Stonepine Capital Management, LLC13G, passive with 3 related filers | 9.9% | March 27, 2026 |
| Thomas A. Satterfield, Jr.13G, passive | 9.9% | May 14, 2026 |
| Nantahala Capital Partners Limited Partnership13G, passive | 6.98% | April 7, 2026 |
Largest institutional holders
Insiders
6 insiders reported holding 399,286 shares in total, about $260.7K at the last price.
| Holder | Shares |
|---|---|
| Dentzer James EPresident & CEO, Director | 148,730 |
| Duvall DianthaCFO | 77,707 |
| Hamdy Ahmed MDCMO | 66,667 |
| Zung Jonathan B.CDO | 66,667 |
| Rubin MarcDirector | 28,108 |
| Kaitin Kenneth IDirector | 11,407 |
Questions about CRIS
What does Curis Inc do?
Curis Inc is a company in the Health care sector, listed on NASDAQ as CRIS. Its shares trade on NASDAQ under the ticker CRIS.
What is Curis Inc's net worth?
Curis Inc has a market value (market cap) of $1.4M at the latest share price, and shareholders' equity of $4.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Curis Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $21.2M on revenue of $4.3M.
How much revenue does Curis Inc make?
Over the twelve months to June 30, 2026 Curis Inc reported revenue of $4.3M. That is 62.2% less than a year earlier.
When did Curis Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare CRIS with
Follow CRIS
Get an email when Curis Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Curis Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.